Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125466982 | 12546698 | 2 | F | 20160720 | 20160711 | 20160721 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK096864 | GLAXOSMITHKLINE | 43.00 | YR | F | Y | 77.50000 | KG | 20160721 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125466982 | 12546698 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
| 125466982 | 12546698 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), QD | 21077 | 1 | DF | INHALATION POWDER | QD | |||||||
| 125466982 | 12546698 | 3 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), QD | R700577 | 21077 | 1 | DF | INHALATION POWDER | QD | ||||||
| 125466982 | 12546698 | 4 | SS | COMPOUND GLYCYRRHIZIN TABLETS | GLYCYRRHIZIN | 1 | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125466982 | 12546698 | 1 | Asthma |
| 125466982 | 12546698 | 4 | Skin disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125466982 | 12546698 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125466982 | 12546698 | Acne | |
| 125466982 | 12546698 | Exophthalmos | |
| 125466982 | 12546698 | Expired product administered | |
| 125466982 | 12546698 | Hepatic function abnormal | |
| 125466982 | 12546698 | Intentional product misuse | |
| 125466982 | 12546698 | Renal impairment | |
| 125466982 | 12546698 | Sputum increased | |
| 125466982 | 12546698 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125466982 | 12546698 | 4 | 2014 | 2015 | 0 |